Overview

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

Status:
Completed
Trial end date:
2019-10-19
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.
Phase:
Phase 3
Details
Lead Sponsor:
Tris Pharma, Inc.
Collaborator:
Premier Research Group plc
Treatments:
Amphetamine